Targeting shared unconventional tumor antigens in cancer immunotherapy
| Website | http://ervimmune.com/ |
| Employees | 19 (9 on RocketReach) |
| Phone | +33 6 67 67 44 97 |
| Industry | Biotechnology Research |
| Keywords | Cancer Immunotherapy, T Cell Therapy, Immuno Oncology, Immune Response, Oncology Therapeutics, Cancer Treatment, Antibody Therapeutics, Cancer Vaccines, Cancer Research, Immunotherapy Research, Novel Therapeutics, Targeted Therapy, Immunotherapeutic Agents, Cancer Drug Development, Clinical Stage Oncology, Biopharmaceutical Research |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Pfizer, Sanofi, GSK, AstraZeneca, Regeneron, Moderna Therapeutics +47 more (view full list) |
Looking for a particular ErVimmune employee's phone or email?
ErVimmune Questions
Stéphane Depil is the Founder and CEO of ErVimmune.
9 people are employed at ErVimmune.
Top ErVimmune Employees
G2Crowd Trusted
300K+
Plugin Users
